Kevin G McLure

Title: Kevin G McLure: Innovator in Complement Pathway Inhibition

Introduction

Kevin G McLure is a notable inventor based in Oakland, CA (US). He has made significant contributions to the field of biomedical research, particularly in the area of complement pathway inhibition. With a total of 5 patents to his name, McLure's work has the potential to impact various medical conditions.

Latest Patents

Among his latest patents, McLure has developed innovative stem-loop compositions and methods for inhibiting factor D. These applications disclose methods and compositions aimed at inhibiting the alternative complement pathway. The methods involve the use of aptamers to inhibit complement Factor D. Furthermore, the applications provide anti-Factor D aptamers for treating conditions such as dry age-related macular degeneration, geographic atrophy, wet age-related macular degeneration, and Stargardt disease. In some instances, stem-loop aptamers are specifically designed for the inhibition of Factor D.

Career Highlights

Throughout his career, McLure has worked with reputable organizations, including Vitrisa Therapeutics, Inc. and Albert Einstein College of Medicine. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.

Collaborations

Some of McLure's notable coworkers include Carl Erickson and Christopher P Rusconi. Their collaborative efforts have contributed to advancements in the understanding and treatment of various medical conditions.

Conclusion

Kevin G McLure stands out as an innovative inventor whose work in complement pathway inhibition holds promise for future medical treatments. His contributions to the field are significant and continue to influence research and development in biomedical sciences.